Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Issuer Symbol
-
COGT on Nasdaq
Fairmount Funds Management LLC - trading volume in the past year for Cogent Biosciences, Inc.
Holdings reported by Fairmount Funds Management LLC for Cogent Biosciences, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Series A Convertible Preferred Stock |
67,414 |
$598,636,320 |
$8880.00 |
22 Jan 2026 |
Fairmount Healthcare Fund II LP |
Common Stock |
16,853,500 |
| Common Stock |
5,503,418 |
$200,324,415 |
$36.40 |
22 Jan 2026 |
Fairmount Healthcare Fund II LP |
|
|
Transactions reported by Fairmount Funds Management LLC for Cogent Biosciences, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.